[1]李天浩,韩晨旭,王惠琴,等.基于EGFR-MUC5AC信号通路探讨参鱼化痰口服液干预慢性阻塞性肺疾病大鼠气道黏液高分泌的机制*[J].陕西中医,2019,(8):995-997,1017.
 LI Tianhao,HAN Chenxu,WANG Huiqin,et al.Based on EGFR-MUC5AC signaling pathway to explore the mechanism of Shenyu Huatan oral liquid in intervention of airway mucus high secretion in COPD rats[J].,2019,(8):995-997,1017.
点击复制

基于EGFR-MUC5AC信号通路探讨参鱼化痰口服液干预慢性阻塞性肺疾病大鼠气道黏液高分泌的机制*
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2019年8期
页码:
995-997,1017
栏目:
基础研究
出版日期:
2019-08-05

文章信息/Info

Title:
Based on EGFR-MUC5AC signaling pathway to explore the mechanism of Shenyu Huatan oral liquid in intervention of airway mucus high secretion in COPD rats
文章编号:
DOI:10.3969/j.issn.1000-7369.2019.08.003
作者:
李天浩韩晨旭王惠琴任加良马建刚△
陕西中医药大学第二附属医院(咸阳 712000 )
Author(s):
LI TianhaoHAN ChenxuWANG Huiqinet al.
Second Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine( Xianyang 712000)
关键词:
慢性阻塞性肺疾病参鱼化痰口服液黏液高分泌粘蛋白大鼠杯状细胞
Keywords:
Key words Chronic obstructive pulmonary diseaseShenyu Huatan oral liquidMucus hypersecretionMucinRatsGoblet cells
分类号:
R563
文献标志码:
A
摘要:
摘 要 目的:观察参鱼化痰口服液对慢性阻塞性肺疾病(COPD)大鼠气道上皮中杯状细胞和粘蛋白 MUC5AC表达的影响,探讨参鱼化痰口服液干预COPD大鼠气道黏液高分泌的可能机制。方法:清洁级SD大鼠随机分为空白组、模型组和中药组(参鱼化痰口服液组),每组12只,按照文献方法建立大鼠COPD模型。支气管肺组织标本中杯状细胞采用阿尔辛蓝过碘酸希夫(ABPAS)染色法检测,以阳染率表示,MUC5AC的表达采用免疫组化法检测。结果:与空白组比较,模型组气道上皮中杯状细胞数显著增加,差异有统计学意义(P<0.01),MUC5AC的表达显著升高,差异有统计学意义(P<0.01)。与模型组比较,中药组杯状细胞数明显减少,差异有统计学意义(P<0.05),MUC5AC的表达明显降低,差异有统计学意义(P<0.05)。结论:参鱼化痰口服液可抑制COPD大鼠气道上皮中杯状细胞增生,减少黏蛋白表达,减轻气道黏液高分泌,其机制可能是通过EGFR-MUC5AC信号通路来实现。
Abstract:
Abstract Objective:To observe the effect of Shenyu Huatan oral liquid on the expression of goblet cells and mucin MUC5AC in airway epithelium of COPD rats,and to explore the possible mechanism of Shenyu Huatan oral liquid in interfering with airway mucus hypersecretion in COPD rats. Methods:SD rats were randomly divided into blank group,model group and Chinese medicine group (Shenyu Huatan oral liquid group),12 rats in each group. The rats COPD model were established according to the literature method. In the bronchopulmonary tissue samples,the goblet cells were detected by Alcian blue periodic acid Schiff (ABPAS) staining,and the expression of MUC5AC was detected by immunohistochemistry. Results:Compared with the blank group,the number of goblet cells in the airway epithelium of the model group was significantly increased (P<0.01),and the expression of MUC5AC was significantly increased (P<0.01). Compared with the model group,the number of goblet cells in the Chinese medicine group was significantly reduced (P<0.05),and the expression of MUC5AC was significantly decreased (P<0.05). Conclusion:Shenyu Huatan oral liquid can inhibit goblet cell hyperplasia in airway epithelium of COPD rats,reduce mucin expression and reduce airway mucus hypersecretion. The mechanism may be achieved by EGFR-MUC5AC signaling pathway.

参考文献/References:

[1] Vestbo J,Prescott E,Lange P,et al. Association of chronic mucus hyper secretion with FEV1 decline and COPD morbidity[J]. Am J Respir Crit Care Med,1996,153(5):1530-1535.
[2] Prescott E,Lange P,Vestbo J. Chronic mucus hyper secretion in COPD and death from pulmonary infection[J]. Eur Respir J,1995,8(8):1333-1338.
[3] Lange P,Ulrik CS,Vestbo J,et al. Mortality in adults with self-reported bronchial asthma. A study of the general population[J]. Lancet,1996,347(9011):1285-1289.
[4] 钟相根,李宇航,祝小惠.慢性阻塞性肺疾病气道黏液高分泌机制及中医药干预作用[J].中华中医药杂志,2011,26(8):1686-1688.
[5] 高 洁,郑爱红,许早荣.清肺化痰逐瘀汤配合西医治疗慢性阻塞性肺疾病急性加重期30例临床观察[J].河北中医,2010,32(10):1505-1508.
[6] 高 洁,段焕发.清肺化痰逐瘀汤配合西药对慢性阻塞性肺疾病急性加重期C 反应蛋白和金属基质蛋白酶-9的影响[J].辽宁中医杂志,2011,38(11):2214-2215.
[7] 高 洁,赵永凯,管思彬.清肺化痰逐瘀汤对慢性阻塞性肺疾病急性加重期患者血清白介素-6和超氧化物歧化酶表达的临床研究[J].四川中医,2013,31(12):65-66.
[8] 李红梅,崔德健,佟 欣,等.熏香烟加气管注内毒素和单纯熏香烟法建立大鼠 COPD模型[J].中国病理生理杂志,2002,18(7):808-812.
[9] Fischer BM,Cuellar JG,Diehl ML,et al.Mucin glycoproteins,gene regulation and goblet cell hyperplasia[J].Am J Respir Cell Mol Physiol,2003,284(4):671-679.
[10] Kirkham S,Sheehan JK,Knight D,et al.Heterogeneity of airways mucus:variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B[J].Biochem J,2002,361(3):537-546.〖JY〗(下转第1017页)〖FL)〗
[11] Dabbagh K,Takeyama K,Leehm,et al.IL- 4 induces mucin gene expression and goblet cell met aplasia in vitro and in vivo[J]. Immunol,1999,162(10):6233- 6237.
[12] Louahed J,Toda M,Jen J,et al.Int erleukin-9 upregulates mucus expression in the airways[J].Am J Respir Cell Mol Biol,2000,22(6):649-656.
[13] Takeyama K,Jung B,S Him JJ,et al.Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke[J].Am J Physi ol Lung Cell Mol Physiol,2001,280(1):165-172.
[14] Levine SJ,Larivee P,Logun C,et al.Tumor necrosis fact oralpha induces mucin hypersecretion and MUC-2 gene expression by human airway epithelial cells[J].Am J Respir Cell Mol Biol,1995,12(2):196-204.
[15] Deshukh HS,Case LM,Wesselkamper SC,et al. Metal loproteinases mediate mucin5AC expression by epidermal growth factor receptor activation[J]. Respir Crit Care Med,2005,171:305-314.
[16] Song JS,Cho KS,Yoon HK. Neutrophil elastase causes MUC5AC mucin synthesis via EGF receptor,ERK and NF-kB pathways in A549 cells[J].Korean J Intern Med,2005,20:275-283.
[17] Huang Z,Ducharme Y,Macdonald D,et al. The next generation of PDEA inhibitors[J]. Qurr Opin Chem Bid,2001,5(4):432-438.
[18] Takayama K,Fahy TV,Nadel JA,et al. Relationship ofwpidermal growth factor receptors to goblet cell production in human brochi [J]. Am J Respir Crit Care Med,2001,163:511-516.

相似文献/References:

[1]杨栓柱,王 文 △,李 猛,等.千金苇茎汤合瓜蒌薤白杏仁汤治疗 慢性阻塞性肺疾病急性加重期临床研究*[J].陕西中医,2019,(5):600.
[2]王 敏,陈 阁.清热化痰祛瘀方联合西药治疗慢性阻塞性肺疾病急性 加重期患者的临床研究[J].陕西中医,2019,(5):610.
 WANG Min,CHEN Ge..Clinical study of Qingre Huatan Quyu prescription combined with western medicine in the treatment of acute exacerbation of chronic obstructive pulmonary disease[J].,2019,(8):610.
[3]王珊珊,谭光波△.补肺汤对慢性阻塞性肺疾病肺气肿大鼠血清IFNγ、IL4表达水平影响研究*[J].陕西中医,2019,(11):1491.
 WANG Shanshan,TAN Guangbo..Effect of Bufei decoction on the expression of IFNγ and IL4 in serum of rats with chronic obstructive pulmonary disease and emphysema[J].,2019,(8):1491.
[4]任英杰,王 起,陈秋生.黄芪汤加减治疗急性加重期慢性阻塞性肺疾病疗效研究[J].陕西中医,2020,(1):57.
 REN Yingjie,WANG Qi,CHEN Qiusheng..Observation on the curative effect of Huangqi decoction in the treatment ofacute exacerbation of chronic obstructive pulmonary disease[J].,2020,(8):57.
[5]聂清华,范伏元△.射干麻黄汤联合沙丁胺醇对慢性阻塞性肺疾病患者肺功能、生活质量的影响[J].陕西中医,2020,(2):180.
 NIE Qinghua,FAN Fuyuan..Effects of Shegan Mahuang decoction and albuterol on pulmonary function and quality of life in patients with COPD[J].,2020,(8):180.
[6]刘新平,王展儒.理肺化痰通脉方治疗慢性阻塞性肺疾病急性加重期临床研究[J].陕西中医,2020,(4):484.
[7]杜沂岚,唐 敏,陈朝晖△,等.经肺腧穴中药离子导入联合振动排痰治疗慢性阻塞性肺疾病急性加重期临床疗效*[J].陕西中医,2020,(4):534.
 DU Yilan,TANG Min,CHEN Zhaohui,et al.Clinical efficacy of Chinese medicine iontophoresis via Feishu point combined with vibration sputum discarding in the treatment of AECOPD[J].,2020,(8):534.
[8]唐颖丽,谢 珊,余清萍,等.子午流注法治疗慢性阻塞性肺疾病加重期痰浊阻肺证疗效研究*[J].陕西中医,2020,(9):1311.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.039]
 TANG Yingli,XIE Shan,YU Qingping,et al.Curative effect of midnight-noon ebb-flow method on chronic obstructive pulmonary disease exacerbation with syndrome of Tanzhuo Zufei[J].,2020,(8):1311.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.039]
[9]蔡东林,孙钟和,赵益庆.慢性阻塞性肺疾病稳定期BODE指数、IL-8、TNF-α水平与肺肾气虚证相关性研究*[J].陕西中医,2020,(11):1573.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.015]
[10]武胜举,王晓青,姚惠青.补肾活血膏方对慢性阻塞性肺疾病稳定期患者抑郁焦虑状态的影响[J].陕西中医,2021,(1):45.[doi:DOI:10.3969/j.issn.1000-7369.2020.01.010]

备注/Memo

备注/Memo:
*陕西省咸阳市科技成果推广计划项目(2018KT-31)
更新日期/Last Update: 2019-08-15